Panacea Biotec Ltd

PANACEABIO
Health CareBiotechnology
SmallcapWith a market cap of ₹902 cr, stock is ranked 1,021
High RiskStock is 3.12x as volatile as Nifty
140.906.35 (-4.31%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareBiotechnology
SmallcapWith a market cap of ₹902 cr, stock is ranked 1,021
High RiskStock is 3.12x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
0.84
PB RatioPB Ratio
-3.90
Dividend YieldDiv. Yield
Sector PESector PE
31.81
Sector PBSector PB
4.71
Sector Div YldSctr Div Yld
0.89%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Panacea Biotec Limited is a health management company. The Company's principal business activity is the manufacture of allopathic pharmaceuticals preparations.

Investor PresentationView older 

Aug 2, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20192020202120220.800.570.632.350.04-0.19-0.151.08
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Newspaper Advertisements 
Announced OnMay 20, 2022

Panacea Biotec Limited has informed the Exchange about Newspaper Advertisements of the Extract of Statement of the Audited Financial Results for quarter and financial year ended March 31, 2022 | Download

Panacea Biotec Limited has informed the Exchange about Newspaper Advertisements of the Extract of Statement of the Audited Financial Results for quarter and financial year ended March 31, 2022 | Download

Financial Result Updates 
Announced OnMay 18, 2022

Panacea Biotec Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022. | Download

Panacea Biotec Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022. | Download

Cash Dividend 
Ex. DateSep 19, 2011

Final • Div/Share: ₹ 0.75

See all events